Carlyle Group’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Hold |
2,948,718
| – | – | 0.04% | 14 |
|
|
2025
Q1 | $2.28M | Hold |
2,948,718
| – | – | 0.06% | 16 |
|
|
2024
Q4 | $2.84M | Hold |
2,948,718
| – | – | 0.07% | 18 |
|
|
2024
Q3 | $4.25M | Hold |
2,948,718
| – | – | 0.45% | 13 |
|
|
2024
Q2 | $3.6M | Hold |
2,948,718
| – | – | 0.34% | 18 |
|
|
2024
Q1 | $6.9M | Buy |
2,948,718
+833,333
| +39% | +$1.95M | 0.44% | 15 |
|
|
2023
Q4 | $3.98M | Hold |
2,115,385
| – | – | 0.19% | 18 |
|
|
2023
Q3 | $2.88M | Hold |
2,115,385
| – | – | 0.12% | 20 |
|
|
2023
Q2 | $5.12M | Hold |
2,115,385
| – | – | 0.18% | 17 |
|
|
2023
Q1 | $12.2M | Buy |
+2,115,385
| New | +$12.2M | 0.36% | 15 |
|